Company signals
Alnylam Pharmaceuticals
1 signal in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: The wider read — a Talent Market Index of 107.8 (Hot), up 2.4 month-on-month — shows EMEA signal flow easing (-8.7pts).
Alnylam Pharmaceuticals: 1 signal in the last 90 days; 0.1% of MitchelLake's EMEA signal flow.
Signals at Alnylam Pharmaceuticals
More signals across EMEA
Partnership · EMEA
Safran →Safran Electronics & Defense signed letter of intent to join Bliksem EXO consortium for exo-atmospheric interceptor development. Safran to provide kill vehicle seeker and guidance, navigation and control systems.
Partnership · EMEA
Arcadis →Arcadis appointed to Transport for London's Professional Services Framework 3, expanding its public sector infrastructure advisory footprint in the UK.
Partnership · EMEA
Revolut →Revolut selected as one of 36 payment service providers to participate in ECB's 12-month digital euro pilot, starting H2 2027. Will test person-to-person and person-to-business transaction capabilities with beta digital euro.
Partnership · EMEA
Adyen →Adyen selected by European Central Bank to participate in digital euro pilot involving 36 payment firms, focusing on cross-border payments within Europe as alternative to US dollar-backed stablecoins.
Partnership · EMEA
BVNK →BVNK secured LemFi as major enterprise client to power stablecoin settlement for 2m+ users across remittance corridors
Partnership · EMEA
Bolt →Bolt is launching Bolt Drive car-sharing in London through a partnership with Hiyacar, a peer-to-peer car-sharing platform. The service will be integrated into the Bolt app from autumn 2026, allowing users to book vehicles without a membership fee. This move capitalizes on the gap left by Zipcar's exit from London.
Intelligence powered by Autonodal ↗